Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PDXen logo — Companies that develop multiple omics-based patient manageme...

PDXen

Companies that develop multiple omics-based patient management systems.

Founded 2013 Korea South Korea South 2 employees Non Equity Assistance Biotechnology, Health Care

General Information

Company Name PDXen
Founded Year 2013
Location Korea South Korea South
Employees 2
Industries Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with PDXen. To contact PDXen, visit pdxen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PDXen compare?

A PDF of PDXen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PDXen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PDXen

PDXen is a South Korean startup focusing on developing omics-based patient management systems. The company specializes in genome analysis and biological characteristics of blood cancer cells, establishing a micro cancer metastatic prediction and anticancer screening system. Utilizing a machine-learning-based algorithm, they aim to predict patient progression and have developed a drug susceptibility analysis system for biological characterization of disease-related cells. Their services and products include Realtime Cell Tracking System, Monitoring System for Minimal Residual Disease, Patient Care Service based on PHR, Patient-derived Xenograft Model Service for Cancer Progression, and Genetic and Microbiome Screening Service. Founded in 2013, PDXen operates in the Biotechnology and Health Care industries from their headquarters in South Korea. While the startup's last investment details are not available at the moment, its innovative approach to cancer management and treatment presents potential opportunities for investors in the biotech and healthcare sectors.

No funding data available for PDXen yet.

FAQ About PDXen

Companies that develop multiple omics-based patient management systems.
PDXen was founded in 2013.
PDXen is headquartered in Korea South.
PDXen operates in Biotechnology and Health Care.
PDXen has approximately 2 employees.

We're actively collecting intelligence on PDXen.

Source: BounceWatch company record for PDXen, https://bouncewatch.com/company/pdxen, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout